
- Telehealth Visits
- Insurance plan information

Neil P. Shah, MD, PhD
Hematology Oncology- Telehealth Visits
- Insurance plan information



Neil P. Shah, MD, PhD
Hematology Oncology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Hematology, American Board of Internal Medicine/Hematology
Fellowship
- Hematology - Oncology, University of California Los Angeles
Residency
- Internal Medicine, University of California Los Angeles
Degree
- MD, University of California Los Angeles
My expertise
Specialties
Conditions
Locations
My research
Publications
Showing 1-6 of 47 reviews
- February 8, 20265 out of 5 Stars
I am so thankful to have the expertise and kind care from Dr. Shah! I appreciate his clear explanations and patience with my questions. I am thankful every day to have such excellent medical care!
- February 1, 20265 out of 5 Stars
Dr. Neil Shah is by far the very best doctor I have ever had. I have dealt with many other doctors, and no other can compare to him. He is brilliant, kind, informative and thorough in every aspect. I will never be able to thank him enough.
- December 13, 20255 out of 5 Stars
Off the charts wonderful. Thank you
- November 27, 20255 out of 5 Stars
Doctor Shah is the best and I would never go anywhere else for excellent care I receive by him and his staff.
- November 27, 20255 out of 5 Stars
I am so very happy with the care I receive from Dr. Shah and team.
- November 26, 20255 out of 5 Stars
Dr Shah saved my life. I respect him as a scientist but dearly love him like my younger brother. He is a kind humble human being with a heart of gold. I am addicted to see him for the rest of my life. Long live Dr. Shah
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.